Healthcare Industry News: Inverness Medical Innovations
News Release - October 1, 2007
Alfred M. Zeien Resigns from the Board of Inverness Medical InnovationsWALTHAM, Mass., Oct. 1 (HSMN NewsFeed) -- Inverness Medical Innovations, Inc. (Amex: IMA ), a leading manufacturer and marketer of rapid diagnostic products for the consumer and professional markets, announced today Alfred M. Zeien has resigned from its Board of Directors, for health reasons.
"We are extremely grateful to Al for the inspired guidance he provided since joining our Board in 2001," said Ron Zwanziger, Chairman, CEO and President. "His experience running The Gillette Company proved a valuable resource to us on many occasions. We wish Al well."
Mr. Zeien's resignation creates vacancies on the Board's compensation and nominating committees, as well as the Board itself. The Company's nominating committee will consider candidates to fill these vacancies.
By developing new capabilities in near-patient diagnosis, monitoring and health management, Inverness Medical Innovations enables individuals to take charge of improving their health and quality of life. A global leader in rapid point-of-care diagnostics, Inverness' products, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women's health. Inverness is headquartered in Waltham, Massachusetts.
Source: Inverness Medical Innovations
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.